• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎的自然史。

Natural history of hepatitis C.

作者信息

Thomas David L, Seeff Leonard B

机构信息

Johns Hopkins School of Medicine, 1503 E. Jefferson Street, Baltimore, MD 21231, USA.

出版信息

Clin Liver Dis. 2005 Aug;9(3):383-98, vi. doi: 10.1016/j.cld.2005.05.003.

DOI:10.1016/j.cld.2005.05.003
PMID:16023972
Abstract

Fifteen years after the discovery of the hepatitis C virus, a substantial amount of information has been learned about the natural history of infection. Testing for viral nucleic acid made it possible to accurately diagnose chronic infection and provided a more precise estimate of the overall frequency of viral persistence. Although cirrhosis and hepatocellular carcinoma can arise in persons with chronic hepatitis C, these outcomes do not always occur. The cirrhosis risk is greater in those who are infected at older ages, those who drink >50 g of alcohol each day, and persons coinfected with HIV. However, much of the person-to-person variability in progression of chronic hepatitis C remains unexplained. The ability to detect persons at highest risk of progression remains incomplete and represents an important future challenge in the understanding of the natural history of hepatitis C.

摘要

丙型肝炎病毒被发现15年后,人们已经了解到大量关于感染自然史的信息。病毒核酸检测使准确诊断慢性感染成为可能,并能更精确地估计病毒持续存在的总体频率。虽然慢性丙型肝炎患者可能会出现肝硬化和肝细胞癌,但这些结果并非总会发生。年龄较大、每天饮酒超过50克以及合并感染艾滋病毒的人患肝硬化的风险更高。然而,慢性丙型肝炎进展过程中人与人之间的许多差异仍无法解释。识别进展风险最高人群的能力仍不完整,这是未来理解丙型肝炎自然史的一项重要挑战。

相似文献

1
Natural history of hepatitis C.丙型肝炎的自然史。
Clin Liver Dis. 2005 Aug;9(3):383-98, vi. doi: 10.1016/j.cld.2005.05.003.
2
[Hepatitis B and C: natural course of disease].[乙型和丙型肝炎:疾病的自然病程]
Acta Med Croatica. 2005;59(5):389-92.
3
Review article: chronic hepatitis C--natural history and cofactors.综述文章:丙型肝炎——自然史及相关因素
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:74-8. doi: 10.1111/j.1365-2036.2005.02602.x.
4
Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.HIV患者中乙型肝炎病毒和丙型肝炎病毒合并感染的影响与管理
Trop Gastroenterol. 2008 Jul-Sep;29(3):136-47.
5
The natural history of childhood-acquired hepatitis C infection in patients with inherited bleeding disorders.遗传性出血性疾病患者儿童期获得性丙型肝炎感染的自然史。
Transfusion. 2006 Aug;46(8):1360-6. doi: 10.1111/j.1537-2995.2006.00903.x.
6
The natural history of recurrent hepatitis C and what influences this.复发性丙型肝炎的自然病史及其影响因素。
Liver Transpl. 2008 Oct;14 Suppl 2:S36-44. doi: 10.1002/lt.21646.
7
Management of chronic hepatitis B and C in HIV-coinfected patients.HIV合并感染患者慢性乙型和丙型肝炎的管理。
J Antimicrob Chemother. 2006 May;57(5):815-8. doi: 10.1093/jac/dkl068. Epub 2006 Mar 23.
8
The changing epidemiology and natural history of hepatitis C virus infection.丙型肝炎病毒感染不断变化的流行病学及自然史。
Clin Liver Dis. 2006 Nov;10(4):697-715. doi: 10.1016/j.cld.2006.08.003.
9
Hepatitis C--clinical profile.丙型肝炎——临床概况。
J Indian Med Assoc. 2007 Aug;105(8):453-4, 456, 465.
10
The natural history of hepatitis C cirrhosis after liver transplantation.肝移植后丙型肝炎肝硬化的自然病史。
Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784.

引用本文的文献

1
Regional Differences in Hepatitis C-Related Hospitalization Rates, United States, 2012-2019.2012 - 2019年美国丙型肝炎相关住院率的地区差异
Public Health Rep. 2025 Jan-Feb;140(1):115-124. doi: 10.1177/00333549241260252. Epub 2024 Jul 26.
2
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate-day treatment in hemodialysis patients with chronic hepatitis C infection.索磷布韦/维帕他韦的药代动力学及在慢性丙型肝炎感染血液透析患者中隔日治疗的疗效。
Clin Transl Sci. 2024 Jul;17(7):e13884. doi: 10.1111/cts.13884.
3
Markers of Natural Killer Cell Exhaustion in HIV/HCV Coinfection and Their Dynamics After HCV Clearance Mediated by Direct-Acting Antivirals.
HIV/HCV合并感染中自然杀伤细胞耗竭的标志物及其在直接作用抗病毒药物介导的HCV清除后的动态变化
Open Forum Infect Dis. 2023 Nov 22;10(12):ofad591. doi: 10.1093/ofid/ofad591. eCollection 2023 Dec.
4
Exposure to Agent Orange and Hepatocellular Carcinoma Among US Military Personnel.接触橙剂与美国军人原发性肝细胞癌
JAMA Netw Open. 2023 Dec 1;6(12):e2346380. doi: 10.1001/jamanetworkopen.2023.46380.
5
Hepatitis C Virus-HIV Coinfection in the United States Among People Who Inject Drugs: Data Needed for Ending Dual Epidemics.美国注射吸毒者中的丙型肝炎病毒与艾滋病病毒合并感染:终结双重疫情所需数据
Public Health Rep. 2023 Jul 22:333549231181348. doi: 10.1177/00333549231181348.
6
Temporal Trends in Hepatitis C-Related Hospitalizations, United States, 2000-2019.2000-2019 年美国丙型肝炎相关住院治疗的时间趋势。
Clin Infect Dis. 2023 Dec 15;77(12):1668-1675. doi: 10.1093/cid/ciad425.
7
Evaluating the utility of a two-assay serological algorithm for hepatitis C screening in a low prevalence population.评估两阶段血清学算法在低流行人群中用于丙型肝炎筛查的效用。
J Clin Lab Anal. 2023 Apr;37(7):e24887. doi: 10.1002/jcla.24887. Epub 2023 Apr 27.
8
Repurposing of drug molecules from FDA database against Hepatitis C virus E2 protein using ensemble docking approach.利用集成对接方法从 FDA 数据库中重新定位针对丙型肝炎病毒 E2 蛋白的药物分子。
Mol Divers. 2024 Jun;28(3):1175-1188. doi: 10.1007/s11030-023-10646-2. Epub 2023 Apr 16.
9
Convergent antibody responses are associated with broad neutralization of hepatitis C virus.聚合抗体反应与广泛中和丙型肝炎病毒有关。
Front Immunol. 2023 Mar 24;14:1135841. doi: 10.3389/fimmu.2023.1135841. eCollection 2023.
10
Challenges Facing Viral Hepatitis C Elimination in Lebanon.黎巴嫩在消除丙型病毒性肝炎方面面临的挑战
Pathogens. 2023 Mar 9;12(3):432. doi: 10.3390/pathogens12030432.